{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T21:10:43Z","timestamp":1654981843064},"reference-count":55,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2069,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1533-2500.2009.00313.x","type":"journal-article","created":{"date-parts":[[2009,10,26]],"date-time":"2009-10-26T11:35:20Z","timestamp":1256556920000},"page":"72-77","source":"Crossref","is-referenced-by-count":11,"title":["The Role of OROS<sup>\u00c2\u00ae<\/sup>Hydromorphone in the Management of Cancer Pain"],"prefix":"10.1111","volume":"10","author":[{"given":"Jackie","family":"Gardner-Nix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Mercadante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1200\/JCO.2004.10.524","article-title":"Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review","volume":"22","author":"McNicol","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00045391-200105000-00006","article-title":"Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia","volume":"8","author":"McCarberg","year":"2001","journal-title":"Am J Ther"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1213\/01.ANE.0000141061.74294.DE","article-title":"The evolving and important role of anesthesiology in palliative care","volume":"100","author":"Fine","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0749-2081(98)80015-6","article-title":"Promoting symptom control in palliative care","volume":"14","author":"Abrahm","year":"1998","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"10.1111\/j.1533-2500.2009.00313.x-BIB5","doi-asserted-by":"crossref","first-page":"iv132","DOI":"10.1093\/annonc\/mdi922","article-title":"World Health Organization guidelines for cancer pain: a reappraisal","volume":"16","author":"Mercadante","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1046\/j.1365-2648.2003.02936.x","article-title":"Morphine is not the only analgesic in palliative care: literature review","volume":"45","author":"Wootton","year":"2004","journal-title":"J Adv Nurs"},{"issue":"11","key":"10.1111\/j.1533-2500.2009.00313.x-BIB7","first-page":"S21","article-title":"Pharmacologic management of cancer pain","volume":"105","author":"Pharo","year":"2005","journal-title":"J Am Osteopath Assoc"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0885-3924(05)80006-5","article-title":"Cancer pain management according to WHO analgesic guidelines","volume":"5","author":"Schug","year":"1990","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB10","first-page":"451","volume-title":"Proceedings of the Second International Congress of Cancer Pain. Advances in Pain Research and Therapy","author":"Ventafridda","year":"1990"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB11","first-page":"ii","volume-title":"Cancer pain","author":"Graham","year":"2004"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Expert working group of the research network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB13","first-page":"1","article-title":"Cancer pain relief and palliative care: report of a WHO expert committee","volume":"804","author":"World Health Organization","year":"1990","journal-title":"WHO Tech Rep Ser"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/104990919801500105","article-title":"Cancer pain management: newer perspectives on opioids and episodic pain","volume":"15","author":"Coluzzi","year":"1998","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1445-5994.2003.00408.x","article-title":"Opioids in palliative care: emerging clinical trends","volume":"33","author":"Ashby","year":"2003","journal-title":"Intern Med J"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpain.2008.01.013","article-title":"Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management","volume":"12","author":"Mercadante","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejpain.2007.01.003","article-title":"Opioid titration in cancer pain: a critical review","volume":"11","author":"Mercadante","year":"2007","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0885-3924(02)00643-7","article-title":"A systematic review of hydromorphone in acute and chronic pain","volume":"25","author":"Quigley","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0885-3924(94)00121-Z","article-title":"Hydromorphone metabolite accumulation in renal failure","volume":"10","author":"Babul","year":"1995","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00000542-199212000-00008","article-title":"Morphine and hydromorphone epidural analgesia. A prospective, randomised comparison","volume":"77","author":"Chaplan","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1460-9592.1999.00370.x","article-title":"Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery","volume":"9","author":"Goodarzi","year":"1999","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"10.1111\/j.1533-2500.2009.00313.x-BIB22","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone","volume":"29","author":"Murray","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM199403033300926","article-title":"New clinical practice guidelines for the management of pain in patients with cancer","volume":"330","author":"Jacox","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.18433\/J3VC75","article-title":"Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms","volume":"10","author":"Kumar","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0885-3924(02)00390-1","article-title":"Dose conversion and titration with a novel, once-daily, OROS\u00c2\u00ae osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain","volume":"23","author":"Palangio","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s005200000183","article-title":"Hydromorphone: pharmacology and clinical applications in cancer patients","volume":"9","author":"Sarhill","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB27","article-title":"Hydromorphone for acute and chronic pain (Review)","author":"Quigley","year":"2007","journal-title":"The Cochrane Library"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(03)00645-0","article-title":"Analgesia in patients with ESRD: a review of available evidence","volume":"42","author":"Kurella","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/026921601669626431","article-title":"Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine","volume":"15","author":"Lee","year":"2001","journal-title":"Palliat Med"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpainsymman.2004.02.021","article-title":"Opioids in renal failure and dialysis patients","volume":"28","author":"Dean","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/00498250110119090","article-title":"Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient","volume":"32","author":"Zheng","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB32","first-page":"332","volume-title":"Concise Guide to Drug Interaction Principles for Medical Practice: Cytochrome P450, UGTs, P-glycoproteins","author":"Cozza","year":"2003"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB33","first-page":"73","article-title":"The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268)","volume":"26","author":"Coffman","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB34","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1007\/BF02854905","article-title":"Role of morphine's metabolites in analgesia: concepts and controversies","volume":"8","author":"Wittwer","year":"2006","journal-title":"AAPS J"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.293.6554.1101","article-title":"Morphine intoxication in renal failure; the role of morphine-6-glucuronide","volume":"293","author":"Osborne","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0885-3924(91)90961-3","article-title":"Chronic nausea and morphine-6-glucuronide","volume":"6","author":"Hagen","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB37","first-page":"22","article-title":"Hydromorphone","volume":"101","author":"Pasero","year":"2001","journal-title":"Am J Nurs"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1185\/030079902125000840","article-title":"Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study","volume":"18","author":"Auiler","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1099-081X(200001)21:1<23::AID-BDD212>3.0.CO;2-V","article-title":"Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects","volume":"21","author":"Modi","year":"2000","journal-title":"Biopharm Drug Dispos"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00002018-200225140-00004","article-title":"Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS\u00c2\u00ae). A retrospective study","volume":"25","author":"Bass","year":"2002","journal-title":"Drug Saf"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00000542-200101000-00014","article-title":"Pharmacodynamics of orally administered sustained-release hydromorphone in humans","volume":"94","author":"Angst","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00000542-200210000-00013","article-title":"Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers","volume":"97","author":"Drover","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB43","unstructured":"43.Opioid analgesic comparison chart provided by MUSC Drug Information Services. Created February 2006, updated September 2006. Available at: http:\/\/www.musc.edu\/pharmacyservices\/medusepol\/OpioidAnalgesicConversionChart.pdf. (accessed September 12, 2008)."},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB44","volume-title":"Handbook of Clinical Drug Data","author":"Anderson","year":"2001"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0300-2977(96)80017-9","article-title":"From compliance to alliance. A quarter century of research","volume":"48","author":"Blackwell","year":"1996","journal-title":"Neth J Med"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB47","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1185\/030079906X132613","article-title":"Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form","volume":"22","author":"Conley","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB48","volume-title":"Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain","author":"American Pain Society","year":"2008"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB49","first-page":"1","article-title":"A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain","volume":"2","author":"Moriarty","year":"1999","journal-title":"J Clin Res"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB50","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1428::AID-CNCR21>3.0.CO;2-0","article-title":"Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain","volume":"79","author":"Hagen","year":"1997","journal-title":"Cancer"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6904-7-3","article-title":"Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone","volume":"7","author":"Sathyan","year":"2007","journal-title":"BMC Clin Pharmacol"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6904-7-2","article-title":"Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food","volume":"7","author":"Sathyan","year":"2007","journal-title":"BMC Clin Pharmacol"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1185\/030079908X253861","article-title":"Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol","volume":"24","author":"Sathyan","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB54","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/147323000803600218","article-title":"Conversion from standard opioid therapy to once-daily oral extended-release hydromorphone in patients with chronic cancer pain","volume":"36","author":"Wallace","year":"2008","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1533-2500.2009.00313.x-BIB55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-7-17","article-title":"A randomized, double-blind comparison of OROS hydromorphone and controlled-release morphine for the control of chronic cancer pain","volume":"7","author":"Hanna","year":"2008","journal-title":"BMC Palliat Care"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1533-2500.2009.00313.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T20:56:34Z","timestamp":1625518594000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2009.00313.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1533-2500.2009.00313.x","relation":{},"ISSN":["1530-7085","1533-2500"],"issn-type":[{"value":"1530-7085","type":"print"},{"value":"1533-2500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}